Ingrid Burvenich
Show
Sort by
-
Synthesis, radiosynthesis and preliminary in vivo evaluation of [123I]-(1-(5-iodo-2-methoxyphenethyl)piperidin-4-yl)(4-fluorophenyl)methanone as a potential SPECT tracer for visualizing the 5-HT2A-receptor
-
Radiosynthesis and in vivo evaluation of 123I-rTIMP-2 as potential SPECT tumour imaging agent
-
123I-EGF internalisation in tumour cells in vitro is inhibited by farnesyltransferase inhibitor therapy: possible target for early therapy response prediction
-
Radiosynthesis and in vivo evaluation of a carboxylic MMP inhibitor as potential SPECT tumour imaging agent
-
Internalization and cellular processing of radiolabeled monoclonal antibody 14C5
-
Precursor synthesis, radiosynthesis and in vivo evaluation in mice of [I-123]-(4-fluorophenyl) {1-[2-(2-iodophenyl)ethyl]piperidin-4-yl}-methanone and -methanol, as potential SPECT tracers for the 5-HT2A-receptor
-
Synthesis, radiosynthesis and preliminary in vivo evaluation of [I-123](4-fluorophenyl) {1-[2-(2(2-iodophenyl)ethyl]piperidin-4-yl}methanone, a potential 5-HT2A-antagonist for SPECT brain imaging
-
Radiolabeling, biodistribution, and dosimetry of I-123-mAb 14C5: A new mAb for radioimmunodetection of tumor growth and metastasis in vivo
-
New strategies in polypeptide and antibody synthesis: An overview